GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Electromedical Technologies Inc (OTCPK:EMED) » Definitions » Debt-to-Revenue

Electromedical Technologies (Electromedical Technologies) Debt-to-Revenue : 1.21 (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Electromedical Technologies Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Electromedical Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1.44 Mil. Electromedical Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.26 Mil. Electromedical Technologies's annualized Revenue for the quarter that ended in Dec. 2023 was $1.41 Mil. Electromedical Technologies's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 1.21.


Electromedical Technologies Debt-to-Revenue Historical Data

The historical data trend for Electromedical Technologies's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Electromedical Technologies Debt-to-Revenue Chart

Electromedical Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
2.97 1.86 1.73 1.72 1.26

Electromedical Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.17 1.00 1.33 1.32 1.21

Competitive Comparison of Electromedical Technologies's Debt-to-Revenue

For the Medical Devices subindustry, Electromedical Technologies's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Electromedical Technologies's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Electromedical Technologies's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Electromedical Technologies's Debt-to-Revenue falls into.



Electromedical Technologies Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Electromedical Technologies's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1.442 + 0.256) / 1.349
=1.26

Electromedical Technologies's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1.442 + 0.256) / 1.408
=1.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.


Electromedical Technologies Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Electromedical Technologies's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Electromedical Technologies (Electromedical Technologies) Business Description

Traded in Other Exchanges
N/A
Address
16561 North 92nd Street, Suite 101, Scottsdale, AZ, USA, 85260
Electromedical Technologies Inc is a bioelectronics manufacturing company. It designs and develops simple-to-use bioelectronics therapy devices, which in major cases provide immediate and long-lasting pain relief across the broadest range of ailments. Its focuses on improving global wellness for people suffering from various painful conditions. It Develops and manufactures bioelectronics products.
Executives
Hymers Iii R. Leslie director 520 S GRAND AVENUE, STE 320, LOS ANGELES CA 90071
Lee Benson director PO BOX 41828, MESA AZ 41828
Donald J Steinberg 10 percent owner 3223 SUMAC ROAD, FALLBROOK CA 92028
Matthew Wolfson director, officer: CEO, CFO 16561 N. 92ND STREET, STE. 101, SCOTTSDALE AZ 85260

Electromedical Technologies (Electromedical Technologies) Headlines